Bin Yu. Leveraging glypican-3 (GPC3)-mediated lysosome-targeting chimeras (GLTACs) for targeted membrane protein degradationJ. Acta Pharmaceutica Sinica B, 2025, 15(4): 2293-2294. DOI: 10.1016/j.apsb.2025.03.044
Citation: Bin Yu. Leveraging glypican-3 (GPC3)-mediated lysosome-targeting chimeras (GLTACs) for targeted membrane protein degradationJ. Acta Pharmaceutica Sinica B, 2025, 15(4): 2293-2294. DOI: 10.1016/j.apsb.2025.03.044
shu

Leveraging glypican-3 (GPC3)-mediated lysosome-targeting chimeras (GLTACs) for targeted membrane protein degradation

    Abstract
    • FullText(HTML)
  • loading
    • References (1)
    • Relative Articles
  • Supplements (0)

Catalog

    Copyright © 2014 Editorial Office of Acta Pharmaceutica Sinica

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return